AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

AI Model for Classifying Breast Cancer From Histopathology Images

Recruitingn/aAges any - anyFemaleTaufiq Hasan, PhD
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Breast cancer, a prevalent and potentially fatal disease, underscores the need for early and accurate detection to improve patient outcomes. Traditional histopathological examination, the current gold standard for diagnosis, faces limitations like subjectivity and low efficiency. In response, this research seeks to revolutionize breast cancer diagnostics by using deep learning techniques to classify invasive and noninvasive breast cancer types from histopathological images. Non-invasive cancers, like DCIS and LCIS, are confined to milk ducts or lobules, while invasive cancers spread to surrounding tissue and make up 70% of cases, often leading to poorer outcomes. The proposed AI model aims to enhance diagnostic accuracy and efficiency, surpassing manual methods, and providing a scalable solution for diverse healthcare settings. By automating image analysis, the model seeks to democratiz

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
* Inclusion criteria: * Female patients of any age can be selected as subjects. * Individuals willing to participate in breast cancer screening. * Availability for biopsy examination. * Women with no current or prior diagnosis of breast cancer. * Availability of relevant medical records for confirmation and comparison purposes. * Exclusion criteria: * Pregnant women are excluded due to potential impacts on screening results and the necessity for special considerations during pregnancy. * Individuals with severe medical conditions or circumstances that may render histopathologic examination inappropriate or unsafe are excluded. * Patients with conditions that could interfere with the accuracy of screening results are excluded. * Follow-up screenings are not included in this study.
๐Ÿ’Š

What it tests

  • Biopsy, Mastectomy, Histopathology
๐Ÿ“

Where

1 site
National Institute of Cancer Research & Hospital (NICRH)
Dhaka, Bangladesh
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy